Vascular Dynamics said it raised nearly $10 million from a group of unnamed investors for the hypertension implant it’s developing.
The Mountain View, Calif.-based startup reported raising $9.7 million in an offering of stock, warrants and other securities as part of a proposed $22.9 million funding round.
Twenty unnamed investors participated in the round, according to a regulatory filing.
Vascular Dynamics was founded in 2008 by Israel-based Rainbow Medical. The company is developing a catheter-delivered carotid sinus implant, MobiusHD, designed to treat drug-resistant hypertension.
The medical device maker began U.S. human clinical trials for MobiusHD in September 2013; a European trial is also under way.
Last year technology giant Sony Corp. (TYO:6758) invested $10 million into Rainbow Medical.